Dapagliflozin lowers plasma glucose concentration and improves β-cell function. [electronic resource]
Producer: 20150930Description: 1927-32 p. digitalISSN:- 1945-7197
- Benzhydryl Compounds -- pharmacology
- Blood Glucose -- drug effects
- C-Peptide -- blood
- Diabetes Mellitus, Type 2 -- blood
- Glucose Tolerance Test
- Glucosides -- pharmacology
- Humans
- Hyperglycemia -- blood
- Hypoglycemic Agents -- pharmacology
- Insulin -- blood
- Insulin-Secreting Cells -- drug effects
- Male
- Middle Aged
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.